Global pharmaceutical giant Eli Lilly & Co. is considering ... $550 million biomanufacturing plant for pharmaceutical company Amgen. Instead, Amgen picked North Carolina's Research Triangle ...

Billions of dollars worth of U.S. biomanufacturing plant development has been announced, and site selection will likely be ...

(Reuters) -Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina ... drugmakers such as Eli Lilly, Johnson & Johnson ...

(Reuters) -Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker ... investments by drugmakers such as ...

Roche has earmarked more than $700 million to construct a sprawling new plant for its Genentech unit in Holly Springs, North Carolina, where myriad large drugmakers have set up production ...

TeamSense ranked all 50 states and the District of Columbia by their level of search interest in manufacturing topics.

Many investments Mr. Trump claims credit for predate his return to office or are based on vague future pledges. Here's a fact ...

Charles R. Goulding and Aaron Rofe reveal how industry leaders like Eli Lilly, Johnson & Johnson, and Roche are going all-in ...

With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out potential sites for new drug ingredients plants. Eli Lilly is jockeying for a ...

Eli Lilly's potential Houston expansion could bring thousands of jobs and billions of dollars in investment to the area. Here's where the plant might be built ...